Journal Article Summary

This article investigates the effectiveness of two antihistamines, cetirizine and mizolastine, in reducing skin reactions caused by histamine, which can lead to symptoms like itching and swelling. Understanding how these medications perform is important because they are commonly used to treat allergic reactions and conditions such as hay fever. By comparing these two drugs, the study aims to provide insights into their relative efficacy and help guide treatment choices for patients experiencing allergic symptoms.

The study involved 36 healthy volunteers aged between 18 and 50 years, who participated in a double-blind, randomized trial. Each participant received either cetirizine, mizolastine, or a placebo, with a wash-out period of about a week between treatments. The researchers measured the skin's response to histamine through prick tests and found that cetirizine significantly outperformed mizolastine in reducing both wheal (raised bumps) and flare (redness) responses at 24 hours after taking the medication. Both medications were generally well-tolerated, with only moderate side effects reported, such as fatigue and somnolence.

Despite the promising results, the study has limitations, including a small sample size and the fact that it only involved healthy volunteers, which may not reflect the responses of patients with allergies. Additionally, while the side effects were mostly mild, patients should always discuss any concerns or potential interactions with their healthcare providers before starting new medications. This conversation is crucial for ensuring safe and effective treatment tailored to individual health needs.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Purohit A, MƩlac M, Pauli G, Frossard N. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h. British Journal of Clinical Pharmacology 2002. DOI: 10.1046/j.0306-5251.2001.01551.x. PMID: 11874388. PMCID: PMC1874315.

Featured Pill Pals Product

Pill PalsĀ® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your medsā„¢. As a Pharmacy Benefits Management organization, Pill PalsĀ® gives patients the best cash prices on all meds. Pill PalsĀ® is part of The Health PalsĀ® Company (Health PalsĀ®, Med PalsĀ®, Skin PalsĀ® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]